Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Villanúa MA[au]:

Search results

Items: 1 to 50 of 87

1.

Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats.

Silva-Peña D, García-Marchena N, Alén F, Araos P, Rivera P, Vargas A, García-Fernández MI, Martín-Velasco AI, Villanúa MÁ, Castilla-Ortega E, Santín L, Pavón FJ, Serrano A, Rubio G, Rodríguez de Fonseca F, Suárez J.

Addict Biol. 2019 Sep;24(5):1019-1033. doi: 10.1111/adb.12668. Epub 2018 Sep 12.

PMID:
30277635
2.

Decreased plasma concentrations of BDNF and IGF-1 in abstinent patients with alcohol use disorders.

García-Marchena N, Silva-Peña D, Martín-Velasco AI, Villanúa MÁ, Araos P, Pedraz M, Maza-Quiroga R, Romero-Sanchiz P, Rubio G, Castilla-Ortega E, Suárez J, Rodríguez de Fonseca F, Serrano A, Pavón FJ.

PLoS One. 2017 Nov 6;12(11):e0187634. doi: 10.1371/journal.pone.0187634. eCollection 2017.

3.

Formoterol decreases muscle wasting as well as inflammation in the rat model of rheumatoid arthritis.

Gómez-SanMiguel AB, Gomez-Moreira C, Nieto-Bona MP, Fernández-Galaz C, Villanúa MÁ, Martín AI, López-Calderón A.

Am J Physiol Endocrinol Metab. 2016 Jun 1;310(11):E925-37. doi: 10.1152/ajpendo.00503.2015.

4.

D-TRP(8)-γMSH Prevents the Effects of Endotoxin in Rat Skeletal Muscle Cells through TNFα/NF-KB Signalling Pathway.

Gómez-SanMiguel AB, Villanúa MÁ, Martín AI, López-Calderón A.

PLoS One. 2016 May 13;11(5):e0155645. doi: 10.1371/journal.pone.0155645. eCollection 2016.

5.

The melanocortin receptor type 3 agonist d-Trp(8)-γMSH decreases inflammation and muscle wasting in arthritic rats.

Gómez-SanMiguel AB, Martín AI, Nieto-Bona MP, Fernández-Galaz C, Villanúa MÁ, López-Calderón A.

J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):79-89. doi: 10.1002/jcsm.12036. Epub 2015 May 11.

6.

Plasma concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: relationship to psychiatric comorbidity.

Pedraz M, Martín-Velasco AI, García-Marchena N, Araos P, Serrano A, Romero-Sanchiz P, Suárez J, Castilla-Ortega E, Barrios V, Campos-Cloute R, Ruiz JJ, Torrens M, Chowen JA, Argente J, de la Torre R, Santín LJ, Villanúa MÁ, Rodríguez de Fonseca F, Pavón FJ.

PLoS One. 2015 Mar 3;10(3):e0118610. doi: 10.1371/journal.pone.0118610. eCollection 2015.

7.

αMSH blunts endotoxin-induced MuRF1 and atrogin-1 upregulation in skeletal muscle by modulating NF-κB and Akt/FoxO1 pathway.

Martín AI, Gómez-SanMiguel AB, Gómez-Moreira C, Villanúa MÁ, López-Calderón A.

Mediators Inflamm. 2014;2014:179368. doi: 10.1155/2014/179368. Epub 2014 Sep 9.

8.

Fenofibrate administration to arthritic rats increases adiponectin and leptin and prevents oxidative muscle wasting.

Castillero E, Martín AI, Nieto-Bona MP, Fernández-Galaz C, López-Menduiña M, Villanúa MÁ, López-Calderón A.

Endocr Connect. 2012 Jun 8;1(1):1-12. doi: 10.1530/EC-12-0003. Print 2012 Jul 1.

9.

Systemic α-melanocyte-stimulating hormone administration decreases arthritis-induced anorexia and muscle wasting.

Gómez-SanMiguel AB, Martín AI, Nieto-Bona MP, Fernández-Galaz C, López-Menduiña M, Villanúa MÁ, López-Calderón A.

Am J Physiol Regul Integr Comp Physiol. 2013 May 15;304(10):R877-86. doi: 10.1152/ajpregu.00447.2012. Epub 2013 Mar 20.

10.

Effect of cyclooxygenase-2 inhibition by meloxicam, on atrogin-1 and myogenic regulatory factors in skeletal muscle of rats injected with endotoxin.

Martin AI, Nieto-Bona MP, Castillero E, Fernandez-Galaz C, Lopez-Menduina M, Gomez-Sanmiguel AB, Gomez-Moreira C, Villanua MA, Lopez-Calderon A.

J Physiol Pharmacol. 2012 Dec;63(6):649-59.

11.

Short-term growth hormone or IGF-I administration improves the IGF-IGFBP system in arthritic rats.

López-Menduiña M, Martín AI, Castillero E, Villanúa MA, López-Calderón A.

Growth Horm IGF Res. 2012 Feb;22(1):22-9. doi: 10.1016/j.ghir.2011.12.003. Epub 2012 Jan 13.

PMID:
22244673
12.

Comparison of the effects of the n-3 polyunsaturated fatty acid eicosapentaenoic and fenofibrate on the inhibitory effect of arthritis on IGF1.

Castillero E, López-Menduiña M, Martín AI, Villanúa MÁ, López-Calderón A.

J Endocrinol. 2011 Sep;210(3):361-8. doi: 10.1530/JOE-11-0170. Epub 2011 Jun 29.

PMID:
21715432
13.

Fenofibrate, a PPAR{alpha} agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy.

Castillero E, Nieto-Bona MP, Fernández-Galaz C, Martín AI, López-Menduiña M, Granado M, Villanúa MA, López-Calderón A.

Am J Physiol Endocrinol Metab. 2011 May;300(5):E790-9. doi: 10.1152/ajpendo.00590.2010. Epub 2011 Feb 8.

14.

Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3.

López-Menduiña M, Martín AI, Castillero E, Villanúa MA, López-Calderón A.

Am J Physiol Regul Integr Comp Physiol. 2010 Aug;299(2):R541-51. doi: 10.1152/ajpregu.00211.2010. Epub 2010 Jun 2.

15.

Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors.

Castillero E, Martín AI, López-Menduiña M, Villanúa MA, López-Calderón A.

Am J Physiol Regul Integr Comp Physiol. 2009 Nov;297(5):R1322-31. doi: 10.1152/ajpregu.00388.2009. Epub 2009 Sep 9.

16.

IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting.

Castillero E, Martín AI, López-Menduiña M, Granado M, Villanúa MA, López-Calderón A.

Mol Cell Endocrinol. 2009 Oct 15;309(1-2):8-16. doi: 10.1016/j.mce.2009.05.017. Epub 2009 Jun 6.

PMID:
19501629
17.

Cyclooxygenase-2 inhibition reverts the decrease in adiponectin levels and attenuates the loss of white adipose tissue during chronic inflammation.

Granado M, Martín AI, Castillero E, López-Calderón A, Villanúa MA.

Eur J Pharmacol. 2009 Apr 17;608(1-3):97-103. doi: 10.1016/j.ejphar.2009.02.030. Epub 2009 Feb 23.

PMID:
19239908
18.

Cyclooxygenase-2 [corrected] activation by endotoxin mediates the decrease in IGF1, but not in IGFBP3, [corrected] gene expression in the liver.

Martín AI, López-Menduiña M, Castillero E, Granado M, Villanúa MA, López-Calderón A.

J Endocrinol. 2008 Aug;198(2):385-94. doi: 10.1677/JOE-08-0205. Epub 2008 May 20. Erratum in: J Endocrinol. 2008 Dec;199(3):501.

PMID:
18492809
19.

Adipose tissue loss in adjuvant arthritis is associated with a decrease in lipogenesis, but not with an increase in lipolysis.

Martín AI, Castillero E, Granado M, López-Menduiña M, Villanúa MA, López-Calderón A.

J Endocrinol. 2008 Apr;197(1):111-9. doi: 10.1677/JOE-07-0491.

PMID:
18372237
20.

GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia.

Granado M, Martín AI, López-Menduiña M, López-Calderón A, Villanúa MA.

Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E131-41. Epub 2007 Nov 6.

21.

Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation.

Granado M, Martín AI, Villanúa MA, López-Calderón A.

Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1656-65. Epub 2007 Feb 6.

22.

Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritic rats.

Granado M, Martín AI, Priego T, López-Calderón A, Villanúa MA.

J Endocrinol. 2006 Oct;191(1):319-26.

PMID:
17065414
23.

Nitric oxide production by hepatocytes contributes to the inhibitory effect of endotoxin on insulin-like growth factor I gene expression.

Priego T, Granado M, Castillero E, Martín AI, Villanúa MA, López-Calderón A.

J Endocrinol. 2006 Sep;190(3):847-56.

PMID:
17003285
24.
25.

Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle.

Granado M, Priego T, Martín AI, Villanúa MA, López-Calderón A.

Am J Physiol Endocrinol Metab. 2005 Dec;289(6):E1007-14. Epub 2005 Jul 19.

26.

Dexamethasone administration attenuates the inhibitory effect of lipopolysaccharide on IGF-I and IGF-binding protein-3 in adult rats.

Priego T, Granado M, Martín AI, López-Calderón A, Villanúa MA.

J Endocrinol. 2005 Jun;185(3):467-76.

PMID:
15930173
27.

Endotoxin administration increases hypothalamic somatostatin mRNA through nitric oxide release.

Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A.

Regul Pept. 2005 Jan 15;124(1-3):113-8.

PMID:
15544848
28.

Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats.

Granado M, Priego T, Martín AI, Villanúa MA, López-Calderón A.

Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E486-92. Epub 2004 Oct 26.

29.

Effect of inducible nitric oxide synthase inhibition by aminoguanidine on insulin-like growth factor binding protein-3 in adjuvant-induced arthritic rats.

Ibáñez de Cáceres I, Priego T, Martín AI, Granado M, López-Calderón A, Villanúa MA.

Eur J Pharmacol. 2003 Nov 28;481(2-3):293-9.

PMID:
14642797
30.

The inhibition of inducible nitric oxide synthase reverts arthritic-induced decrease in pituitary growth hormone mRNA but not in liver insulin-like growth factor I mRNA expression.

Ibáñez de Cáceres I, Priego T, Martín AI, López-Calderón A, Villanúa MA.

J Neuroendocrinol. 2003 Dec;15(12):1178-84.

PMID:
14636180
31.

Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats.

Priego T, Granado M, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A.

J Endocrinol. 2003 Oct;179(1):107-17.

PMID:
14529571
32.

NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver.

Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A.

Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E50-6. Epub 2003 Sep 16.

33.

Endotoxin decreases serum IGFBP-3 and liver IGFBP-3 mRNA: comparison between Lewis and Wistar rats.

Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A.

Mol Cell Endocrinol. 2003 Jan 31;199(1-2):23-8.

PMID:
12581876
34.

Hepatic insulin-like growth factor-I binding protein 3 gene expression in rats with endotoxic shock: the role of glucocorticoids.

Priego T, Ibañez De Cáceres I, Martín AI, Villanúa MA, López-Calderón A.

Ann N Y Acad Sci. 2002 Nov;973:88-90.

PMID:
12485840
35.

GH administration and renal IGF-I system in arthritic rats.

Ibáñez de Cáceres I, Priego T, Martín AI, López-Calderón A, Villanúa MA.

Life Sci. 2002 May 31;71(2):139-51.

PMID:
12031684
36.

Circadian rhythms in airline pilots submitted to long-haul transmeridian flights.

Ariznavarreta C, Cardinali DP, Villanúa MA, Granados B, Martín M, Chiesa JJ, Golombek DA, Tresguerres JA.

Aviat Space Environ Med. 2002 May;73(5):445-55.

PMID:
12014603
37.

Arthritis-induced increase in serum levels of IGF-binding protein-3 in rats is secondary to the decrease in its proteolytic activity.

Ibáñez De Cáceres I, Holly JM, Priego T, Martín AI, López-Calderón A, Villanúa MA.

J Endocrinol. 2002 May;173(2):357-64.

PMID:
12010643
38.

Glucocorticoids are not necessary for the inhibitory effect of endotoxic shock on serum IGF-I and hepatic IGF-I mRNA.

Priego T, Ibáñez de Cáceres I, Martín AI, Villanúa MA, López-Calderón A.

J Endocrinol. 2002 Mar;172(3):449-56.

PMID:
11874693
39.

Effects of an endurance cycling competition on resting serum insulin-like growth factor I (IGF-I) and its binding proteins IGFBP-1 and IGFBP-3.

Chicharro JL, López-Calderon A, Hoyos J, Martín-Velasco AI, Villa G, Villanúa MA, Lucía A.

Br J Sports Med. 2001 Oct;35(5):303-7.

40.

Circadian urinary 6-sulphatoxymelatonin, cortisol excretion and locomotor activity in airline pilots during transmeridian flights.

Tresguerres JA, Ariznavarreta C, Granados B, Martín M, Villanúa MA, Golombek DA, Cardinali DP.

J Pineal Res. 2001 Aug;31(1):16-22.

PMID:
11485000
41.

Functional interaction between opioid and cannabinoid receptors in drug self-administration.

Navarro M, Carrera MR, Fratta W, Valverde O, Cossu G, Fattore L, Chowen JA, Gomez R, del Arco I, Villanua MA, Maldonado R, Koob GF, Rodriguez de Fonseca F.

J Neurosci. 2001 Jul 15;21(14):5344-50.

42.

The decrease in hepatic IGF-I gene expression in arthritic rats is not associated with modifications in hepatic GH receptor mRNA.

Lopez-Calderon A, Ibáñez de Caceres I, Soto L, Priego T, Martin AI, Villanua MA.

Eur J Endocrinol. 2001 May;144(5):529-34.

PMID:
11331220
43.

IGF-I and IGF-I-binding proteins in rats with adjuvant-induced arthritis given recombinant human growth hormone.

Ibañez De Cáceres I, Villanúa MA, Soto L, Martin AI, López-Calderón A.

J Endocrinol. 2000 Jun;165(3):537-44.

PMID:
10828837
44.

Maternal exposure to the synthetic cannabinoid HU-210: effects on the endocrine and immune systems of the adult male offspring.

del Arco I, Muñoz R, Rodríguez De Fonseca F, Escudero L, Martín-Calderón JL, Navarro M, Villanúa MA.

Neuroimmunomodulation. 2000;7(1):16-26.

PMID:
10601815
45.

Diurnal oscillation in glial fibrillary acidic protein in a perisuprachiasmatic area and its relationship to the luteinizing hormone surge in the female rat.

Fernandez-Galaz MC, Martinez Muñoz R, Villanua MA, Garcia-Segura LM.

Neuroendocrinology. 1999 Nov;70(5):368-76.

PMID:
10567863
46.

Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide.

González S, Romero J, de Miguel R, Lastres-Becker I, Villanua MA, Makriyannis A, Ramos JA, Fernández-Ruiz JJ.

Life Sci. 1999;65(3):327-36.

PMID:
10447218
47.

The effect of cyclosporine administration on growth hormone release and serum concentrations of insulin-like growth factor-I in male rats.

López-Calderón A, Soto L, Villanúa MA, Vidarte L, Martín AI.

Life Sci. 1999;64(17):1473-83.

PMID:
10353612
48.

Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion.

Murphy LL, Muñoz RM, Adrian BA, Villanúa MA.

Neurobiol Dis. 1998 Dec;5(6 Pt B):432-46. Review.

PMID:
9974176
49.

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.

Navarro M, Chowen J, Rocío A Carrera M, del Arco I, Villanúa MA, Martin Y, Roberts AJ, Koob GF, de Fonseca FR.

Neuroreport. 1998 Oct 26;9(15):3397-402.

PMID:
9855288
50.

Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs.

de Miguel R, Romero J, Muñoz RM, García-Gil L, González S, Villanua MA, Makriyannis A, Ramos JA, Fernández-Ruiz JJ.

Biochem Pharmacol. 1998 Nov 15;56(10):1331-8.

PMID:
9825732

Supplemental Content

Loading ...
Support Center